Related Experiment Video
Updated: May 13, 2026

Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS
Published on: December 21, 2011
Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?
Susana Rovira-Llopis1, Milagros Rocha, Rosa Falcon
11 Fundacion para la Investigacion Sanitaria y Biomedica de la Comunidad Valenciana FISABIO, Endocrinology Service, University Hospital Doctor Peset , Valencia, Spain .
Abstract:
It is still unclear whether microvascular complications of type 2 diabetes correlate with leukocyte-endothelium interactions and/or myeloperoxidase (MPO) levels. In the present study, we found that serum levels of glucose, the rate of ROS and MPO concentration were higher in type 2 diabetic patients. Patients with nephropathy (39.6%) presented higher MPO levels that correlate positively with the albumin/creatinine ratio (r = 0.59, p<0.05). In addition, nephropatic patients showed increased leukocyte-endothelium interactions due to an undermining of polymorphonuclear leukocytes (PMN) rolling velocity and increased rolling flux and adhesion, which was accompanied by a rise in levels of the proinflammatory cytokine tumour necrosis factor alpha (TNFα) and the adhesion molecule E-selectin. Furthermore, MPO levels were positively correlated with PMN rolling flux (r = 0.855, p < 0.01) and adhesion (r = 0.682, p<0.05). Our results lead to the hypothesis that type 2 diabetes induces oxidative stress and an increase in MPO levels and leukocyte-endothelium interactions, and that these effects correlate with the development of nephropathy.
Insights
Type 2 diabetes is linked to higher oxidative stress, indicated by increased myeloperoxidase (MPO) levels and heightened leukocyte-endothelium interactions. These factors correlate with the development of diabetic nephropathy.
Area of Science:
- Endocrinology
- Nephrology
- Immunology
Background:
- Microvascular complications in type 2 diabetes are not fully understood.
- The roles of leukocyte-endothelium interactions and myeloperoxidase (MPO) in these complications require clarification.
Purpose of the Study:
- To investigate the correlation between type 2 diabetes, microvascular complications, leukocyte-endothelium interactions, and MPO levels.
- To explore the relationship between MPO, oxidative stress, and the development of nephropathy in type 2 diabetes.
Main Methods:
- Measured serum glucose, reactive oxygen species (ROS) rate, and MPO concentration in type 2 diabetic patients.
- Assessed leukocyte-endothelium interactions, including polymorphonuclear leukocyte (PMN) rolling velocity, flux, and adhesion.
- Quantified levels of tumor necrosis factor alpha (TNFα) and E-selectin.
Main Results:
- Type 2 diabetic patients exhibited elevated glucose, ROS, and MPO levels.
- Patients with nephropathy showed significantly higher MPO levels, positively correlating with the albumin/creatinine ratio.
- Nephropathic patients displayed increased PMN rolling, adhesion, and elevated TNFα and E-selectin, with MPO levels correlating positively with PMN rolling flux and adhesion.
Conclusions:
- Type 2 diabetes induces oxidative stress, increasing MPO levels and leukocyte-endothelium interactions.
- These elevated MPO levels and interactions are associated with the progression of diabetic nephropathy.
Related Concept Videos
Diabetic Nephropathy
Diabetic Retinopathy
Diabetic Neuropathy
Type II Diabetes II: Pathophysiology
